版本:
中国

BRIEF-Therapix Biosciences names Josh Blacher CFO

May 3 Therapix Biosciences Ltd:

* Therapix Biosciences announces the appointment of Josh Blacher as chief financial officer

* Prior to joining Therapix, Blacher served as Chief Financial Officer at Galmed Pharmaceuticals Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐